Genomics health technology startup Color is doing its part to deal with the global COVID-19 pandemic, and has actually detailed the steps it’s requiring to support growth of screening efforts in a brand-new article and letter from CEO Othman Laraki on Tuesday. The efforts include advancement of a high-throughput laboratory that can process as lots of as 10,000 tests per day, with a turnaround time of within 24 hours for reporting results to doctors. In order to supply the most benefit possible from the effort of standing this laboratory up, Color will likewise make the design, procedures and specifics of this lab available open-source to anybody else looking to establish high-capacity laboratory testing.

Color’s laboratory is also currently nearly prepared to start processing samples– it’s going live “in the coming week,” according to Laraki. The Color group operated in tandem with MIT’s Broad Institute, in addition to Harvard and Weill Cornell Medication to develop its procedure and screening techniques that can allow for higher bandwidth results output versus standard, in-use techniques.

The focus of Color’s efforts in making this take place have actually been on utilizing automation wherever possible, and seeking strategies that source parts and components, consisting of reagents, that can come from different supply chains. That’s really a vital active ingredient to being able to ramp efforts at scale nationally and internationally, due to the fact that if everyone is using the exact same laboratory processing approaches, you’re going to run up against a traffic jam quite quickly in regards to materials. Being able to process 10s of countless tests per day is terrific on paper, however it means absolutely nothing if one active ingredient you need to make that take place is likewise needed by every other screening lab in the nation.

Color has actually likewise made efforts to resolve COVID-19 response in two other crucial locations: testing for front-line and important employees, and post-test follow-up and processing. To deal with the requirement for testing for those workers who continue to operate in public-facing functions despite the risks, Color has actually redirected its business staff member base to supplying, in tandem with federal governments and companies, onsite medical test administration, lab transport and results reporting with client doctors.

For its post-test workflow, Color is working to resolve the challenges reported by other clinicians and health officials around how difficult it is to be efficient and consistent in acting on the outcomes of tests, in addition to next actions. So the business is opening up their own platform for doing so, which they’ve re-tooled in reaction to their experience to date, and making that readily available to any other COVID-19 screening labs for free usage. These resources consist of test result reporting, guidelines and instructions for clients, follow-up questionnaires around contact tracing and support for how to connect to possibly exposed individuals connected to a patient who evaluates positive.

To date, Color states that it has been able to run at cost, in part backed by support by philanthropic public and personal contributions. The company is encouraging direct outreach through its covid-response@color.com!.?.! e-mail in case anyone thinks they can contribute to or benefit from the task and the resources being provided. Article curated by RJ Shara from Source. RJ Shara is a Bay Area Radio Host (Radio Jockey) who talks about the startup ecosystem – entrepreneurs, investments, policies and more on her show The Silicon Dreams. The show streams on Radio Zindagi 1170AM on Mondays from 3.30 PM to 4 PM.